UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients

JNCI : Journal of the National Cancer Institute, 2014-05, Vol.106 (5), p.1

2014

Volltextzugriff (PDF)

Adjuvant aromatase inhibitor therapy: Outcomes and safety

Cancer treatment reviews, 2010-05, Vol.36 (3), p.249-261

2010

Volltextzugriff (PDF)

Obesity as an independent risk factor for decreased survival in node-positive high-risk breast cancer

Breast cancer research and treatment, 2015-06, Vol.151 (3), p.569-576

2015

Volltextzugriff (PDF)

Lack of Effect of Adjuvant Chemotherapy on the Elimination of Single Dormant Tumor Cells in Bone Marrow of High-Risk Breast Cancer Patients

Journal of clinical oncology, 2000-01, Vol.18 (1), p.80-86

2000

Volltextzugriff (PDF)

Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients

European journal of cancer (1990), 2013-05, Vol.49 (8), p.1825-1835

2013

Volltextzugriff (PDF)

Comparative Analysis of Micrometastasis to the Bone Marrow and Lymph Nodes of Node-Negative Breast Cancer Patients Receiving No Adjuvant Therapy

Journal of clinical oncology, 2001-03, Vol.19 (5), p.1468-1475

2001

Volltextzugriff (PDF)

βV-tubulin expression is associated with outcome following taxane-based chemotherapy in non-small cell lung cancer

British journal of cancer, 2012-08, Vol.107 (5), p.823-830

2012

Volltextzugriff (PDF)

Einfluss des BMI auf die Effektivität der Aromataseinhibition

Der Onkologe, 2011-03, Vol.17 (3), p.248-250

2011

Volltextzugriff (PDF)

Occult Tumor Cells in Bone Marrow of Patients With Locoregionally Restricted Ovarian Cancer Predict Early Distant Metastatic Relapse

Journal of clinical oncology, 2001-01, Vol.19 (2), p.368-375

2001

Volltextzugriff (PDF)

Association of CA27.29 and Circulating Tumor Cells Before and at Different Times After Adjuvant Chemotherapy in Patients with Early-stage Breast Cancer - The SUCCESS Trial

Anticancer research, 2016-09, Vol.36 (9), p.4771-4776

2016

Volltextzugriff (PDF)

BYON4228 is a pan-allelic antagonistic SIRPα antibody that potentiates destruction of antibody-opsonized tumor cells and lacks binding to SIRPγ on T cells

Journal for immunotherapy of cancer, 2023-04, Vol.11 (4), p.e006567

2023

Volltextzugriff (PDF)

Monoclonal Antibody Therapy with Edrecolomab in Breast Cancer Patients: Monitoring of Elimination of Disseminated Cytokeratin-positive Tumor Cells in Bone Marrow

Clinical cancer research, 1999-12, Vol.5 (12), p.3999-4004

1999

Volltextzugriff (PDF)

Use of Granulocyte-colony Stimulating Factor During Chemotherapy and Its Association With CA27.29 and Circulating Tumor Cells—Results From the SUCCESS A Trial

Clinical breast cancer, 2018-10, Vol.18 (5), p.e1103-e1110

2018

Volltextzugriff (PDF)

Folylpoly-Glutamate Synthetase Expression Is Associated with Tumor Response and Outcome from Pemetrexed-Based Chemotherapy in Malignant Pleural Mesothelioma

Journal of thoracic oncology, 2012-09, Vol.7 (9), p.1440-1448

2012

Volltextzugriff (PDF)

The German SUCCESS C Study – The First European Lifestyle Study on Breast Cancer

Breast care (Basel, Switzerland), 2010-01, Vol.5 (6), p.395-400

2010

Volltextzugriff (PDF)

Quality of Life Influenced by Primary Surgical Treatment for Stage I-III Breast Cancer--Long-Term Follow-Up of a Matched-Pair Analysis

Annals of surgical oncology, 2001, Vol.8 (6), p.542-548

Janni, W.

2001

Volltextzugriff (PDF)

The fate and prognostic value of occult metastatic cells in the bone marrow of patients with breast carcinoma between primary treatment and recurrence

Cancer, 2001-07, Vol.92 (1), p.46-53

2001

Volltextzugriff (PDF)

Prevalence of CA 27.29 in Primary Breast Cancer Patients before the Start of Systemic Treatment

Anticancer research, 2010-05, Vol.30 (5), p.1837-1841

2010

Volltextzugriff (PDF)

Treosulfan as an Effective Second-Line Therapy in Ovarian Cancer

Gynecologic oncology, 1998-10, Vol.71 (1), p.94-98

1998

Volltextzugriff (PDF)

Prognostic significance of an increased number of micrometastatic tumor cells in the bone marrow of patients with first recurrence of breast carcinoma

Cancer, 2000-05, Vol.88 (10), p.2252-2259

2000

Volltextzugriff (PDF)

Photodynamic therapy in women with cervical intraepithelial neoplasia using topically applied 5‐aminolevulinic acid

International journal of cancer, 1999-03, Vol.81 (1), p.34-38

1999

Volltextzugriff (PDF)

Patterns of disease recurrence influenced by hematogenous tumor cell dissemination in patients with cervical carcinoma of the uterus

Cancer, 2003-01, Vol.97 (2), p.405-411

2003

Volltextzugriff (PDF)

The role of chemoradiotherapy in the treatment of stage III non-small-cell lung cancer

Annals of oncology, 2004-01, Vol.15 (suppl-4), p.iv71-iv80

2004

Volltextzugriff (PDF)

Chemosensitivity testing in gynecologic oncology--dream or reality?

Recent results in cancer research, 2003, Vol.161, p.146

2003

Volltextzugriff (PDF)

Squamous cell carcinoma antigen and carcinoembryonic antigen levels as prognostic factors for the response of cervical carcinoma to chemotherapy

Gynecologic oncology, 1990-07, Vol.38 (1), p.6-11

1990

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(29)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(28)
Science & Technology
(28)
Humans
(25)
Female
(23)
Biological And Medical Sciences
(18)
Medical Sciences
(18)
Middle Aged
(14)
Prognosis
(13)
Tumors
(12)
Gynecology. Andrology. Obstetrics
(10)
Adult
(9)
Breast Neoplasms - Pathology
(9)
Aged
(8)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(7)
Breast Neoplasms - Drug Therapy
(7)
Chemotherapy, Adjuvant
(7)
Neoplasm Staging
(7)
Breast Cancer
(6)
Chemotherapy
(6)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients

Adjuvant aromatase inhibitor therapy: Outcomes and safety

Obesity as an independent risk factor for decreased survival in node-positive high-risk breast cancer

Lack of Effect of Adjuvant Chemotherapy on the Elimination of Single Dormant Tumor Cells in Bone Marrow of High-Risk Breast Cancer Patients

Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients

Comparative Analysis of Micrometastasis to the Bone Marrow and Lymph Nodes of Node-Negative Breast Cancer Patients Receiving No Adjuvant Therapy

βV-tubulin expression is associated with outcome following taxane-based chemotherapy in non-small cell lung cancer

Einfluss des BMI auf die Effektivität der Aromataseinhibition

Occult Tumor Cells in Bone Marrow of Patients With Locoregionally Restricted Ovarian Cancer Predict Early Distant Metastatic Relapse

Association of CA27.29 and Circulating Tumor Cells Before and at Different Times After Adjuvant Chemotherapy in Patients with Early-stage Breast Cancer - The SUCCESS Trial

BYON4228 is a pan-allelic antagonistic SIRPα antibody that potentiates destruction of antibody-opsonized tumor cells and lacks binding to SIRPγ on T cells

Monoclonal Antibody Therapy with Edrecolomab in Breast Cancer Patients: Monitoring of Elimination of Disseminated Cytokeratin-positive Tumor Cells in Bone Marrow

Use of Granulocyte-colony Stimulating Factor During Chemotherapy and Its Association With CA27.29 and Circulating Tumor Cells—Results From the SUCCESS A Trial

Folylpoly-Glutamate Synthetase Expression Is Associated with Tumor Response and Outcome from Pemetrexed-Based Chemotherapy in Malignant Pleural Mesothelioma

The German SUCCESS C Study – The First European Lifestyle Study on Breast Cancer

Quality of Life Influenced by Primary Surgical Treatment for Stage I-III Breast Cancer--Long-Term Follow-Up of a Matched-Pair Analysis

The fate and prognostic value of occult metastatic cells in the bone marrow of patients with breast carcinoma between primary treatment and recurrence

Prevalence of CA 27.29 in Primary Breast Cancer Patients before the Start of Systemic Treatment

Treosulfan as an Effective Second-Line Therapy in Ovarian Cancer

Prognostic significance of an increased number of micrometastatic tumor cells in the bone marrow of patients with first recurrence of breast carcinoma

Photodynamic therapy in women with cervical intraepithelial neoplasia using topically applied 5‐aminolevulinic acid

Patterns of disease recurrence influenced by hematogenous tumor cell dissemination in patients with cervical carcinoma of the uterus

The role of chemoradiotherapy in the treatment of stage III non-small-cell lung cancer

Chemosensitivity testing in gynecologic oncology--dream or reality?

Squamous cell carcinoma antigen and carcinoembryonic antigen levels as prognostic factors for the response of cervical carcinoma to chemotherapy

Aktive Filter

Suchergebnisse filtern